SCHEMBL5576537

SCHEMBL5576537

CCc1nc(Sc2ccc(CC(=O)O)cc2)ccc1C=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.41
LMNA P02545 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
CYP26A1 O43174 1/20 0.38
GAA P10253 2/20 0.37
ALDH1A1 P00352 2/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
GSTP1 P09211 1/20 0.34
GSTM2 P28161 1/20 0.34
CA2 P00918 1/20 0.34
CAMK2A Q9UQM7 1/20 0.34
CASP6 P55212 1/20 0.34
PTGDR2 Q9Y5Y4 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SRC P12931 1/20 0.33
CHEK2 O96017 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4596630 0.86 CYP26A1 (0.40) TP53LMNARXFP1CYP26A1GAA
SCHEMBL4596971 0.72 CYP4F2 (0.41) GAAALDH1A1HPGDNPC1RAB9A
SCHEMBL13464286 0.69 CA2 (0.60) LMNACYP26A1GAAALDH1A1HPGD
SCHEMBL4596529 0.68 TYMS (0.44) LMNAGAAALDH1A1HPGDHSD17B10
SCHEMBL4598185 0.68 NR4A1 (0.41) TP53LMNARXFP1GAAALDH1A1
SCHEMBL46640 0.66 CA2 (0.56) LMNACYP26A1GAAALDH1A1HPGD
SCHEMBL11565077 0.65 CYP26A1 (0.51) LMNACYP26A1GAAALDH1A1HPGD
SCHEMBL13463033 0.65 LMNA (0.39) TP53LMNARXFP1ALDH1A1HPGD
SCHEMBL11301868 0.65 AKR1B1 (0.64) LMNACYP26A1GAAALDH1A1HPGD
SCHEMBL156207 0.64 ALDH1A1 (0.63) TP53LMNAGAAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070066624-A1 Chemokine receptor binding compounds ANORMED, INC. (CA) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066624-A1 Chemokine receptor binding compounds CCR5, CCR4, CCR1 TP53 2854/4885LMNA 4700/4885RXFP1 707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.